Showing 4271-4280 of 5627 results for "".
- CooperVision Specialty EyeCare Launches Optimized Pupil Optics for Onefit MED and Onefit MED+ Scleral Lenseshttps://modernod.com/news/coopervision-specialty-eyecare-launches-optimized-pupil-optics-for-onefit-med-and-onefit-med-scleral-lenses/2480394/CooperVision Specialty EyeCare announced the launch of Optimized Pupil Optics (OPO) for its Onefit MED and Onefit MED+ scleral contact lenses to eye care providers (ECPs) in the United States and Canada. The new high precision design option—which is supported by an
- CooperVision Presents Presbyopia Research, Introduces MyDay Daily Disposable Multifocal at Academy 2021https://modernod.com/news/coopervision-presents-presbyopia-research-introduces-myday-daily-disposable-multifocal-at-academy-2021/2480390/As part of the American Academy of Optometry 2021 virtual press conference, CooperVision presented results of research into the daily complexity of dealing with presbyopia and how this may affect clinical choices. The work was conducted in support of the launch of CooperVision’s new MyDay&n
- FDA Clears Emergency Use of Comirnaty in Children Aged 5 to 11https://modernod.com/news/fda-clears-emergency-use-of-comirnaty-in-children-aged-5-to-11/2480386/The FDA on Friday authorized emergency use of Pfizer and BioNTech's Comirnaty for the prevention of COVID-19 to include children 5 through 11 years of age. The vaccine is administered as a two-dose primary series, 21 days apart, but at a lower 10-mcg dose than that used for individuals 12 yea
- Ocular Therapeutix to Present Data at the American Academy of Ophthalmology (AAO) 2021 Virtual Annual Meetinghttps://modernod.com/news/ocular-therapeutix-to-present-data-at-the-american-academy-of-ophthalmology-aao-2021-virtual-annual-meeting/2480384/Ocular Therapeutix announced multiple scientific presentations at the American Academy of Ophthalmology (AAO) 2021 Annual Meeting being held November 12-15, 2021. “We are happy to have a large presence at AAO this year with six poster presentations in five different indicatio
- EyeCare Partners Acquires CEI Vision Partnershttps://modernod.com/news/eyecare-partners-acquires-cei-vision-partners/2480383/EyeCare Partners (ECP) announced it entered into an agreement to acquire CEI Vision Partners (CVP), a network of ophthalmology practices in the Midwest and Mid-Atlantic. Financial terms of the transaction were not disclosed. The deal will create a combined group of more t
- EyeGate Pharmaceuticals Closes Acquisition of Bayon Therapeuticshttps://modernod.com/news/eyegate-pharmaceuticals-closes-acquisition-of-bayon-therapeutics/2480376/EyeGate Pharmaceuticals announced that it has completed the planned acquisition of Bayon Therapeutics and has appointed Eric J. Daniels, MD, MBA, as its Chief Development Officer, effective as of October 21, 2021. Dr. Daniels will drive ongoing development of EyeGate’
- Ocular Therapeutix's Phase 2 Clinical Trial of OTX-CSI for the Treatment of Dry Eye Disease Does Not Meet Primary Endpointhttps://modernod.com/news/ocular-therapeutixs-phase-2-clinical-trial-of-otx-csi-for-the-treatment-of-dry-eye-disease-does-not-meet-primary-endpoint/2480372/Topline results from Ocular Therapeutix's phase 2 clinical trial of OTX-CSI (cyclosporine intracanalicular insert) for the treatment of dry eye disease (DED) did not meet its primary endpoint of increased tear production at 12 weeks. The phase 2, US-based, randomized, double-masked,
- Aurion Biotech Names Members of Medical Advisory Boardhttps://modernod.com/news/aurion-biotech-names-members-of-medical-advisory-board/2480358/Aurion Biotech announced the company’s medical advisory board, composed of the world’s most eminent ophthalmologists. The board will collaborate with the company’s executive team in clinical development, and is chaired by Edward Holland, MD, who was recently
- Stephen D. McLeod, MD, Selected as Next CEO of American Academy of Ophthalmologyhttps://modernod.com/news/stephen-d-mcleod-md-selected-as-next-ceo-of-american-academy-of-ophthalmology/2480346/The American Academy of Ophthalmology board of trustees announced the unanimous selection of Stephen D. McLeod, MD, 57, as the Academy’s next chief executive officer (CEO). Dr. McLeod currently is the Theresa M. and Wayne M. Caygill, M.D. Distinguished Professor and Chair, Department of Oph
- 2021 American Academy of Optometry & Foundation Resident Travel Fellowship Recipientshttps://modernod.com/news/2021-american-academy-of-optometry-foundation-resident-travel-fellowship-recipients/2480331/The American Academy of Optometry and its Foundation would like to congratulate the recipients of this year’s Resident Travel Fellowships. These travel fellowsh